1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The role of imatinib in the treatment of pulmonary hypertension.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Imatinib mesylate, a receptor tyrosine kinase inhibitor that has been approved for several oncology conditions, is currently under investigation for pulmonary arterial hypertension. The therapeutic rationale is that its targets, platelet-derived growth factor receptor beta (PDGFR-β) and proto-oncogene c-Kit, are pivotal for the proliferation, migration and apoptosis resistance of peripheral artery smooth muscle cells which reduces the lumen of the pulmonary artery, leading to diminished blood oxygenation and pressure overload in the right heart ventricle. Interfering with this process could slow disease progression, which is incompletely addressed by current therapies which focus on vasorelaxation. Results from two efficacy studies have been reported; while the first missed its primary endpoint (but provided valuable insights on efficacy in subgroups), the phase III IMPRES study and its ongoing extension revealed an impressive degree of added benefit for imatinib against a background of conventional combination therapy. The side effect profile of imatinib in this condition requires more investigation.

          Related collections

          Author and article information

          Journal
          Drugs Today
          Drugs of today (Barcelona, Spain : 1998)
          Prous Science
          1699-3993
          1699-3993
          Mar 2013
          : 49
          : 3
          Affiliations
          [1 ] H.M. Pharma Consultancy, Austria. h.mucke@hmpharmacon.com.
          Article
          1937430
          10.1358/dot.2013.49.3.1937430
          23527324
          27e8f01b-a58c-4730-bc48-2a689220218e

          Peripheral artery smooth muscle cells,Blood oxygenation,Pulmonary arterial hypertension,Pressure overload,Imatinib mesylate

          Comments

          Comment on this article